Blood Systems Inc.

Shares of Cerus Corporation (NASDAQ: CERS), a biomedical products company, jumped higher by nearly 2 percent on Tuesday after the company announced a master agreement with Blood Systems, Inc. (BSI) for the use of INTERCEPT Blood System for platelets and plasma. BSI and its affiliates distribute 240...